InflaRx NV (IFRX)
1.33
-0.08
(-5.67%)
USD |
NASDAQ |
May 02, 16:00
1.33
0.00 (0.00%)
After-Hours: 19:41
InflaRx Cash from Operations (TTM): -40.94M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -40.94M |
| September 30, 2023 | -36.18M |
| June 30, 2023 | -32.22M |
| March 31, 2023 | -32.45M |
| December 31, 2022 | -35.58M |
| September 30, 2022 | -42.72M |
| June 30, 2022 | -52.26M |
| March 31, 2022 | -49.13M |
| December 31, 2021 | -47.25M |
| September 30, 2021 | -43.64M |
| June 30, 2021 | -43.65M |
| March 31, 2021 | -42.65M |
| December 31, 2020 | -41.72M |
| Date | Value |
|---|---|
| September 30, 2020 | -49.69M |
| June 30, 2020 | -47.39M |
| March 31, 2020 | -50.32M |
| December 31, 2019 | -48.37M |
| September 30, 2019 | -37.75M |
| June 30, 2019 | -33.18M |
| March 31, 2019 | -28.03M |
| December 31, 2018 | -25.45M |
| September 30, 2018 | -21.57M |
| June 30, 2018 | -21.32M |
| March 31, 2018 | -17.92M |
| December 31, 2017 | -13.76M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-52.26M
Minimum
Jun 2022
-32.22M
Maximum
Jun 2023
-42.48M
Average
-42.72M
Median
Sep 2022
Cash from Operations (TTM) Benchmarks
| Affimed NV | -119.38M |
| MorphoSys AG | -- |
| BioNTech SE | 5.815B |
| Immatics NV | 19.73M |
| CureVac NV | -290.02M |